The Kotak Nifty 100 Low Vol 30 ETF, managed by Kotak Mahindra Asset Management Company, aims to replicate the NIFTY 100 Low Volatility 30 Index, focusing on low volatility investments.

This open-ended scheme employs a tracking approach to align closely with the NIFTY 100 Low Volatility 30 TRI, targeting returns that mirror the benchmark while managing tracking errors.

The fund's portfolio exhibits notable concentration in the Pharmaceuticals and Biotechnology sector, comprising 13.76%, with key holdings such as DR Reddy's Laboratories and Sun Pharmaceuticals leading the allocation.

Performance has been commendable, with a 1-year return of +9.7% and a robust 3-year CAGR of 17.0%, indicating consistent growth relative to its low volatility investment strategy.

With an AUM of ₹178.99 Cr and an expense ratio of 0.09%, the fund maintains operational efficiency, supported by experienced fund managers, ensuring liquidity and accessibility for investors.